Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bruce L Zuraw & Sandra C Christiansen. (2008) New promise and hope for treating hereditary angioedema. Expert Opinion on Investigational Drugs 17:5, pages 697-706.
Read now
Read now
Articles from other publishers (35)
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
805
808
.
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
2
.
Daniel Ricklin & John D. Lambris. 2013. Complement Therapeutics. Complement Therapeutics
1
22
.
Robert A. DeAngelis, Edimara S. Reis, Daniel Ricklin & John D. Lambris. (2012) Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis. Immunobiology 217:11, pages 1097-1105.
Crossref
Crossref
Marjolein Heeres, Tjaakje Visser, Karlijn JP van Wessem, Anky HL Koenderman, Paul FW Strengers, Leo Koenderman & Luke PH Leenen. (2011) The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial. Trials 12:1.
Crossref
Crossref
Lokesh A Rukmangadachar, Jitender Kataria, Gururao Hariprasad, Jyotish C Samantaray & Alagiri Srinivasan. (2011) Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clinical Proteomics 8:1.
Crossref
Crossref
Sandra C. Christiansen & Bruce L. Zuraw. (2011) Hereditary Angioedema: Management of Laryngeal Attacks. American Journal of Rhinology & Allergy 25:6, pages 379-382.
Crossref
Crossref
Lubka T. Roumenina, Maria Radanova, Boris P. Atanasov, Krastio T. Popov, Srinivas V. Kaveri, Sébastien Lacroix-Desmazes, Véronique Frémeaux-Bacchi & Jordan D. Dimitrov. (2011) Heme Interacts with C1q and Inhibits the Classical Complement Pathway. Journal of Biological Chemistry 286:18, pages 16459-16469.
Crossref
Crossref
G. Bahat, S. Akin, F. Tufan, A. Gelincik, N. Erten & M.A. Karan. (2010) Gesichtsödem als Frühsymptom einer RiesenzellarteriitisFacial edema as an earlier presenting sign of giant cell arteritis. Zeitschrift für Rheumatologie 70:2, pages 160-162.
Crossref
Crossref
H. Davis Massey & Richard A. McPherson. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods
914
932
.
Bruce L Zuraw. (2010) HAE therapies: past present and future. Allergy, Asthma & Clinical Immunology 6:1.
Crossref
Crossref
P.F.W. Strengers & Ch. P. Pescott. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
591
606
.
Bodil Salvesen, Erik W. Nielsen, Morten Harboe, Ola D. Saugstad & Tom E. Mollnes. (2009) Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood. Molecular Immunology 46:4, pages 688-694.
Crossref
Crossref
Daniel Ricklin & John D Lambris. (2007) Complement-targeted therapeutics. Nature Biotechnology 25:11, pages 1265-1275.
Crossref
Crossref
Erik Waage Nielsen, Christian Waage, Hilde Fure, Ole L. Brekke, Georgia Sfyroera, John D. Lambris & Tom E. Mollnes. (2007) Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Molecular Immunology 44:8, pages 1819-1826.
Crossref
Crossref
Menaka Karmegam & Richard J. Quigg. 2007. The Kidney in Systemic Autoimmune Diseases. The Kidney in Systemic Autoimmune Diseases
43
62
.
Bruce L. Zuraw. (2006) Novel Therapies for Hereditary Angioedema. Immunology and Allergy Clinics of North America 26:4, pages 691-708.
Crossref
Crossref
Jochen Poling, Mehmet Oezkur, Karina Kogge, Michael Mengel, Heiner Niemann, Michael Winkler, Axel Haverich & Karsten Wiebe. (2006) Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins. Transplant International 19:3, pages 225-232.
Crossref
Crossref
Tom E. Mollnes & Michael Kirschfink. (2006) Strategies of therapeutic complement inhibition. Molecular Immunology 43:1-2, pages 107-121.
Crossref
Crossref
Claudio Storini, Emanuela Rossi, Veronica Marrella, Maria Distaso, Robert Veerhuis, Carlo Vergani, Luigi Bergamaschini & Maria-Grazia De Simoni. (2005) C1-inhibitor protects against brain ischemia–reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiology of Disease 19:1-2, pages 10-17.
Crossref
Crossref
Vijaykumar R. Holla, Dingzhi Wang, Joanne R. Brown, Jason R. Mann, Sharada Katkuri & Raymond N. DuBois. (2005) Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer. Journal of Biological Chemistry 280:1, pages 476-483.
Crossref
Crossref
Bruce L. Zuraw. (2005) Current and future therapy for hereditary angioedema. Clinical Immunology 114:1, pages 10-16.
Crossref
Crossref
Maria Grazia De Simoni, Emanuela Rossi, Claudio Storini, Simone Pizzimenti, Cinara Echart & Luigi Bergamaschini. (2004) The Powerful Neuroprotective Action of C1-Inhibitor on Brain Ischemia-Reperfusion Injury Does Not Require C1q. The American Journal of Pathology 164:5, pages 1857-1863.
Crossref
Crossref
Roland S Croner, Thorsten G Lehmann, Christina Fallsehr, Christian Herfarth, Ernst Klar & Michael Kirschfink. (2004) C1-inhibitor reduces hepatic leukocyte–endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat. Microvascular Research 67:2, pages 182-191.
Crossref
Crossref
Tom Eirik Mollnes. 2004. The Complement System. The Complement System
483
516
.
Markus S. Huber-Lang, J. Vidya Sarma, Firas S. Zetoune & Peter A. Ward. 2004. The Complement System. The Complement System
465
480
.
Bruce L Zuraw. (2003) Diagnosis and management of hereditary angioedema: an American approach. Transfusion and Apheresis Science 29:3, pages 239-245.
Crossref
Crossref
Yong Shen & Seppo Meri. (2003) Yin and Yang: complement activation and regulation in Alzheimer’s disease. Progress in Neurobiology 70:6, pages 463-472.
Crossref
Crossref
M. van der Flier, S. P. M. Geelen, J. L. L. Kimpen, I. M. Hoepelman & E. I. Tuomanen. (2003) Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome?. Clinical Microbiology Reviews 16:3, pages 415-429.
Crossref
Crossref
Deepak Bhole & Gregory L. Stahl. (2003) Therapeutic potential of targeting the complement cascade in critical care medicine. Critical Care Medicine 31:Supplement, pages S97-S104.
Crossref
Crossref
Glen A. Toomayan, Long-En Chen, Hai-Xiang Jiang, Wen-Ning Qi, Anthony V. Seaber, Michael M. Frank & James R. Urbaniak. (2003) C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. Microsurgery 23:6, pages 561-567.
Crossref
Crossref
E. W. Nielsen, T. E. Mollnes, J. M. Harlan & R. K. Winn. (2002) C1-Inhibitor Reduces the Ischaemia-Reperfusion Injury of Skeletal Muscles in Mice after Aortic Cross-Clamping. Scandinavian Journal of Immunology 56:6, pages 588-592.
Crossref
Crossref
Thomas Sulikowski, Bryan A. Bauer & Philip A. Patston. (2009) α1-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1. Protein Science 11:9, pages 2230-2236.
Crossref
Crossref
Richard J Quigg. (2002) Use of complement inhibitors in tissue injury. Trends in Molecular Medicine 8:9, pages 430-436.
Crossref
Crossref
Tom E Mollnes, Wen-Chao Song & John D Lambris. (2002) Complement in inflammatory tissue damage and disease. Trends in Immunology 23:2, pages 61-64.
Crossref
Crossref